Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, in the State of Gujarat. Over the last six decades, the company has been developing and manufacturing pharmaceutical products in India and selling and distributing these in over 100 countries around the world.
Cadila Pharmaceuticals Sweden was established in 2013 to initiate and manage collaborations between Cadila group companies and European companies, investors and institutions. With our partners, we are involved in research, development, manufacturing and commercial collaborations. As a pharmaceutical company we operate as a fully integrated development organization, ranging from CMC, pre-clinical to clinical studies with an extensive network of clinicians across India. We are open to make our highly efficient development machinery available to our European collaborators on a shared-risk basis.
Our highly flexible business model adds value to pharmaceutical, biotech, diagnostics or medtech companies by advancing scientific and technical opportunities to exit-ready assets, whether it entails performing proof-of-concept clinical studies or bringing products to consumers or patients. To life science investors, we add value by de-risking and shortening development and commercialization timelines, while also providing companies the knowledge and credibility associated with having a major pharmaceutical partner as a co-investor.
Cadila Pharmacuticals Sweden Vision
We will be a key contributor in building Cadila Pharmaceuticals’ pipeline and skill base through unique access to innovation
Through creative business development and leveraging Cadila Pharmaceuticals R&D capabilities, we will be a valued partner for European life science companies
We will become an empowered competency hub of talented staff and advisors
Board of Directors
Story of Cadila Pharma
Born on February 18, 1926, in a small village of Hansot in Bharuch district of South Gujarat, Indravadan Ambalal Modi has left a long lasting impact on the Indian Pharmaceuticals industry. With a vision of making medicines affordable to the last man of society, Cadila has throughout the years fostered many innovations to bring them to the Indian market at a reasonable price.
After higher studies of pharmaceuticals and fine chemicals at Mumbai University, at the age of 25 Modi quit his job as a chemist in a chemical manufacturing unit and founded Cadila Laboratories in 1951 together with business partner Ramanbhai Patel.
The operations evolved over the decades to one of the largest pharmaceutical companies in India. In 1995 the company was restructured into two parts, with the Modi family’s share of the company being renamed to Cadila Pharmaceuticals. The company has since remained a family owned business that today employs over 9,500 people with presence in over 100 countries.
Modi has also played an important role in the development of the Indian pharmaceutical Industry by influencing government policies and national legislation.
In 2012, Modi passed away at the age of 87 years. Since then the company is chaired by his son, Dr. Rajiv Modi. Cadila Pharmaceuticals has continued to grow and today has a strong global presence with operations in Europe, USA, Japan and Africa.
Corporate Social Responsibility
Cadila Pharmaceuticals has a number of CSR activities running for the benefit of the community, focusing on the areas of health, education, women’s empowerment and child care. The center of these activities is the Kaka-Ba Hospital which was set up in 1985 by Cadila Pharmaceuticals’ founder Indravadan Modi to serve the local community with quality medical services and health and hygiene awareness and education.
Kaka-Ba Hospital has played a pivotal role in comprehensive and sustainable development and has emerged as a successful rural healthcare model. Over the three decades of operation more than 500,000 patients have been treated. The hospital has also helped more than 3,000 patients with physical deformities like cleft lip or post burn contracture with plastic surgeries. All of the services of the hospital are provided free or at very nominal charges.
In addition to serving the community with healthcare, the Kaka-Ba Trust is also working with disease prevention projects such as bringing water purification plants to the nearby villages.
More information about the Kaka-Ba Hospital and pictures from the operations can be found at www.kakabatrust.org
Cadila Pharmaceuticals Sweden AB is a wholly owned step-down subsidiary of Cadila Pharmaceuticals Limited, Ahmedabad, India.
More information about the parent company can be found at www.cadilapharma.com